Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116899) titled 'Rituximab Efficacy versus Mycophenolate mofetil In Sustaining remission of Steroid sensitive frequently relapsIng Or steroid dependent Nephrotic syndrome' on Sept. 2.

Study Type: Interventional

Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Stratified block randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Open Label

Primary Sponsor: ICMR

Condition: Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes

Intervention: Intervention1: Rituximab: Intravenously at a do...